Search

At Memorial Sloan Kettering, we offer rehabilitation services for people after surgery as well as for those receiving outpatient treatment for tracheal diseases.

… At Memorial Sloan Kettering, we offer rehabilitation services for people after surgery as well as for those receiving outpatient treatment for tracheal diseases. Postoperative Pulmonary Program To help patients recover immediately after surgery, Memorial Sloan Kettering offers a Postoperative Pulmonary

Learn about this rare melanoma, which usually appears as a pink or red spot on the skin.

… Amelanotic melanoma refers to a rare variant of skin cancer. It begins when the melanocytes in the skin grow out of control and form tumors. Melanocytes are the cells responsible for making melanin, the pigment that determines the color of the skin. Amelanotic melanoma is different from other skin melanomas

Obtenga más información sobre este melanoma poco común, que generalmente aparece como una mancha rosa o roja en la piel.

… El melanoma amelanótico se trata de una variante poco común de cáncer de piel. Comienza cuando los melanocitos de la piel crecen sin control y forman tumores. Los melanocitos son las células encargadas de producir melanina, el pigmento que determina el color de la piel. El melanoma amelanótico se diferencia

Find a concise overview of salivary gland anatomy.

… If you have been diagnosed with salivary gland cancer, knowing a little bit about the salivary glands will help you talk to your doctor about surgery or other aspects of your care. The salivary glands make saliva and empty it into your mouth through openings called ducts. Saliva helps with swallowing

… Your immune system is a powerful tool against infection. But sometimes the immune system goes into overdrive, working against the very body it was designed to protect. These “autoimmune” disorders can affect blood cells. At MSK Kids, our hematologists have experience treating rare, severe autoimmune

Find out what clinical trials are taking place for squamous cell skin cancer at MSK.

… Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies that are not yet readily available. Below is a listing of squamous cell carcinoma clinical trials that are currently enrolling

Our team of specialists will shape a treatment approach that makes sense for you. Learn more about our primary bone cancer experts.

… We’ve been diagnosing and treating primary bone cancer for many decades. As with every type of cancer, we bring together specialists from all areas of bone cancer care to treat you. Our disease management team includes surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists

If your child has been diagnosed with leukemia, Memorial Sloan Kettering is ready to help. Get answers to your questions, and learn about our approach to treatment.

… Leukemia is the most common type of cancer in children. About 30 percent of all cancers that affect children and young adults are leukemia. It is most commonly diagnosed between ages 2 and 10. Leukemia begins in tissues that produce blood cells. The good news is that about 90 percent of children diagnosed

Experts at MSK are among the most experienced in the nation at treating pituitary gland tumors through surgery, medication, radiation therapy, and more. Learn about our approach to care.

… Surgery is the primary treatment recommended for most pituitary tumors. And for many people, that’s the only treatment needed. Others, particularly those with prolactinomas , may need medications or radiation therapy . The treatment recommended by your doctor largely depends on the symptoms you are having

Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from MGUS.

… Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from MGUS. MGUS (pronounced like EM-gus) is when your blood makes an abnormal (not normal) protein called m-protein